1
ALL1
Beech Tree LabsYear
1
ALL1
2020DEALS // DEV.
1
ALL1
DevelopmentsCountry
1
ALL1
U.S.A1
ALL1
InapplicableTherapeutic Area
1
ALL1
Infections and Infectious DiseasesStudy Phase
1
ALL1
UndisclosedDeal Type
1
ALL1
InapplicableProduct Type
1
ALL1
Other Small MoleculeDosage Form
1
ALL1
Sublingual Solution/DropsLead Product
1
ALL1
ThimerosalTarget
1
ALL1
UndisclosedLead Product(s) : Thimerosal
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Beech Tree Labs is Developing a Potential Antiviral Therapy to Fight COVID-19 Pandemic
Details : Beech Tree Labs sponsored two Phase 2 clinical trials that demonstrated the safety and efficacy of TML to reduce the onset of Herpes virus lesions after exposure to dental procedure or sunlight. The p value of the combined studies was 0.019. No adverse e...
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 04, 2020
Lead Product(s) : Thimerosal
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable